• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
HPI
Click for more information
0.00% $3.73

HOTEL PROPERTY INVESTMENTS - News & Media

Market Cap $733.2M  ! watchlist Created with Sketch. Add to my watchlist

Hotel Property Investments Limited is an Australia-based real estate investment company.... Hotel Property Investments Limited is an Australia-based real estate investment company. The principal activity of the Company consists of real estate investment in the pub sector in Australia. The Company owns a portfolio of approximately 57 Australian convenience hotel properties, predominantly located on the eastern seaboard and leased to the Queensland Venue Company1 and Australian Venue Company. Its properties include Ball Court Hotel, Beenleigh Tavern, Berserker Tavern, Bonny View Tavern, Boomerang Motor Hotel, Bribie Island Hotel, Brighton Hotel, Brighton Metro Hotel, Capella Hotel Motel, Chancellors Tavern, Cleveland Sands Hotel, Cleveland Tavern, Commercial Hotel, Commonwealth Hotel, Coomera Lodge Hotel, Cornerstone Ale House, Crown Hotel, Royal Mail Hotel, Gregory Hills Hotel and others. More

No News & Media currently available.

(20min delay)
Last
$3.73 		Change
0.000(0.00%) 		Mkt cap ! $733.2M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 454 $3.75
 

Sellers (Offers)

Price($) Vol. No.
$3.74 3435 2
View Market Depth
Last trade - 09.56am 02/10/2024 (20 minute delay) ?
HPI (ASX) Chart

Top Stories

Firebird achieves preliminary approvals for its Jinshi plant design

Firebird Metals Ltd has reached a significant stage in development of its battery-grade manganese sulphate plant in China
Canada orders national security review over CGN's 11.26% opposition to Paladin-Fission deal Paladin has disclosed its attempted takeover of Fission Uranium Corp was blocked by a Chinese shareholder late last month.
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.